CRDFNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Cardiff Oncology, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026
$0.89−0.02 (-1.71%)
Close on Oct 19, 2026
- Market cap
- $60.58M
- P/E (TTM)
- –
- Dividend yield
- –
Price history
Daily open, high, low, close and volume
| Date | Open | High | Low | Close | Change | Volume |
|---|---|---|---|---|---|---|
| Daily prices are not in StockData yet. This table fills in once an end-of-day price source is connected. | ||||||
Stock splits
From SEC filings
| Date | Ratio | Effect on per-share figures |
|---|---|---|
| Mar 6, 2019(first seen in filings) | 1-for-6 reverse | Earlier per-share figures multiplied by 6 |
| Feb 20, 2019 | 1-for-6 reverse | Earlier per-share figures multiplied by 6 |
| Aug 3, 2018(first seen in filings) | 1-for-12 reverse | Earlier per-share figures multiplied by 12 |
| Jun 4, 2018 | 1-for-12 reverse | Earlier per-share figures multiplied by 12 |
| May 30, 2012 | 1-for-6 reverse | Earlier per-share figures multiplied by 6 |
| May 29, 2012 | 1-for-6 reverse | Earlier per-share figures multiplied by 6 |
| Jul 27, 2004 | 111-for-1 | Earlier per-share figures divided by 111 |